My Quote Request
6505-01-366-5017
20 Products
NDC00536-3541-01
CYANOCOBALAMIN TABLETS
NSN, MFG P/N
6505013665017
NSN
6505-01-366-5017
NDC00536-3541-01
CYANOCOBALAMIN TABLETS
NSN, MFG P/N
6505013665017
NSN
6505-01-366-5017
MFG
RUGBY GROUP INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 50.000 MICROGRAMS CYANOCOBALAMIN ACTIVE INGREDIENT
ADMINISTRATION: ORAL
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
CORGARD TABLETS
NADOLOL TABLETS,USP
NSN, MFG P/N
6505013660939
NSN
6505-01-366-0939
MFG
BRISTOL-MYERS SQUIBB CO WESTWOOD-SQUIBB PHARMACEUTICALS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS NADOLOL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NADOLOL TABLETS USP 20MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD, BRISTOL-MYERS SQUIBB CO
Related Searches:
F92I168
NADOLOL TABLETS,USP
NSN, MFG P/N
6505013660939
NSN
6505-01-366-0939
MFG
AIR FORCE MEDICAL LOGISTICS OFFICE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS NADOLOL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NADOLOL TABLETS USP 20MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD, BRISTOL-MYERS SQUIBB CO
Related Searches:
NDC00003-0232-50
NADOLOL TABLETS,USP
NSN, MFG P/N
6505013660939
NSN
6505-01-366-0939
MFG
SQUIBB E R AND SONS INC WORLD HQ
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 20.000 MILLIGRAMS NADOLOL ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NADOLOL TABLETS USP 20MG 100S BT
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD, BRISTOL-MYERS SQUIBB CO
Related Searches:
F92I233
LEVOTHYROXINE SODIUM TABLETS,USP
NSN, MFG P/N
6505013660962
NSN
6505-01-366-0962
F92I233
LEVOTHYROXINE SODIUM TABLETS,USP
NSN, MFG P/N
6505013660962
NSN
6505-01-366-0962
MFG
AIR FORCE MEDICAL LOGISTICS OFFICE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 MICROGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVOTHYROXINE SODIUM TABLETS USP 75MCG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00048-1050-05
LEVOTHYROXINE SODIUM TABLETS,USP
NSN, MFG P/N
6505013660962
NSN
6505-01-366-0962
NDC00048-1050-05
LEVOTHYROXINE SODIUM TABLETS,USP
NSN, MFG P/N
6505013660962
NSN
6505-01-366-0962
MFG
BOOTS PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 MICROGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVOTHYROXINE SODIUM TABLETS USP 75MCG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC52604-5075-02
LEVOTHYROXINE SODIUM TABLETS,USP
NSN, MFG P/N
6505013660962
NSN
6505-01-366-0962
NDC52604-5075-02
LEVOTHYROXINE SODIUM TABLETS,USP
NSN, MFG P/N
6505013660962
NSN
6505-01-366-0962
MFG
JONES MEDICAL INDUSTRIES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 MICROGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVOTHYROXINE SODIUM TABLETS USP 75MCG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
SYNTHROID
LEVOTHYROXINE SODIUM TABLETS,USP
NSN, MFG P/N
6505013660962
NSN
6505-01-366-0962
SYNTHROID
LEVOTHYROXINE SODIUM TABLETS,USP
NSN, MFG P/N
6505013660962
NSN
6505-01-366-0962
MFG
BOOTS PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 MICROGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVOTHYROXINE SODIUM TABLETS USP 75MCG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
SYNTHROID TABLETS
LEVOTHYROXINE SODIUM TABLETS,USP
NSN, MFG P/N
6505013660962
NSN
6505-01-366-0962
SYNTHROID TABLETS
LEVOTHYROXINE SODIUM TABLETS,USP
NSN, MFG P/N
6505013660962
NSN
6505-01-366-0962
MFG
BOOTS PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 75.000 MICROGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: LEVOTHYROXINE SODIUM TABLETS USP 75MCG 1000S BT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00536-1950-78
MAGNESIA AND ALUMINA ORAL SUSPENSION,USP
NSN, MFG P/N
6505013661452
NSN
6505-01-366-1452
NDC00536-1950-78
MAGNESIA AND ALUMINA ORAL SUSPENSION,USP
NSN, MFG P/N
6505013661452
NSN
6505-01-366-1452
MFG
RUGBY GROUP INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 200.000 MILLIGRAMS MAGNESIUM HYDROXIDE PER 5 MILLILITERS AND 225.000 MILLIGRAMS ALUMINUM HYDROXIDE GEL, DRIED PER 5 MILLILITERS
ADMINISTRATION: ORAL
FLAVOR: MINT
PRIMARY CONTAINER CONTENT QUANTITY: 26.000 FLUID OUNCES OR 769.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: NON-CONSTIPATING ANTACID SUSPENSION
Related Searches:
14602
HALOPERIDOL TABLETS,USP
NSN, MFG P/N
6505013663058
NSN
6505-01-366-3058
MFG
GOLDLINE LABORATORIES GOVERNMENT SALES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS HALOPERIDOL ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: EXPIRATION DATED
Related Searches:
NDC00182-1854-05
HALOPERIDOL TABLETS,USP
NSN, MFG P/N
6505013663058
NSN
6505-01-366-3058
NDC00182-1854-05
HALOPERIDOL TABLETS,USP
NSN, MFG P/N
6505013663058
NSN
6505-01-366-3058
MFG
GOLDLINE LABORATORIES GOVERNMENT SALES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS HALOPERIDOL ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: EXPIRATION DATED
Related Searches:
NDC00536-3880-05
HALOPERIDOL TABLETS,USP
NSN, MFG P/N
6505013663058
NSN
6505-01-366-3058
NDC00536-3880-05
HALOPERIDOL TABLETS,USP
NSN, MFG P/N
6505013663058
NSN
6505-01-366-3058
MFG
RUGBY GROUP INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.000 MILLIGRAMS HALOPERIDOL ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: EXPIRATION DATED
Related Searches:
NDC00536-3879-05
HALOPERIDOL TABLETS,USP
NSN, MFG P/N
6505013663059
NSN
6505-01-366-3059
NDC00536-3879-05
HALOPERIDOL TABLETS,USP
NSN, MFG P/N
6505013663059
NSN
6505-01-366-3059
MFG
RUGBY GROUP INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 5.000 MILLIGRAMS HALOPERIDOL ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
PROTECTIVE STORAGE FEATURE: EXPIRATION DATED
Related Searches:
ACTIVASE
ALTEPLASE FOR INJECTION
NSN, MFG P/N
6505013663202
NSN
6505-01-366-3202
MFG
GENENTECH INC.
Description
FEATURES PROVIDED: DILUENT AND STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ALTEPLASE FOR INJECTION 58000000 INTERNATIONAL UNITS
PHYSICAL FORM: FREEZE-DRIED POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 58000000.000 INTERNATIONAL UNITS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: 58 MILLION I.U. OF ALTEPLASE EQUIV. PER 100 MG; ALSO CONTAINS 3.5 GRAMS L-ARGININE,1 GRAM PHOSPHORIC ACID,AND LESS THAN 11 MG POLYSORBATE 80; RECOMBINANT; W/ONE 100 ML VIAL OF STERILE WATER FOR INJECTION,USP AND ONE TRANSFER DEVICE; FOR USE AS A
TOTAL PRIMARY CONTAINER QUANTITY: 1
~1: THROMBOLYTIC AGENT
Related Searches:
NDC50242-0085-27
ALTEPLASE FOR INJECTION
NSN, MFG P/N
6505013663202
NSN
6505-01-366-3202
NDC50242-0085-27
ALTEPLASE FOR INJECTION
NSN, MFG P/N
6505013663202
NSN
6505-01-366-3202
MFG
GENENTECH INC.
Description
FEATURES PROVIDED: DILUENT AND STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ALTEPLASE FOR INJECTION 58000000 INTERNATIONAL UNITS
PHYSICAL FORM: FREEZE-DRIED POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 58000000.000 INTERNATIONAL UNITS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: 58 MILLION I.U. OF ALTEPLASE EQUIV. PER 100 MG; ALSO CONTAINS 3.5 GRAMS L-ARGININE,1 GRAM PHOSPHORIC ACID,AND LESS THAN 11 MG POLYSORBATE 80; RECOMBINANT; W/ONE 100 ML VIAL OF STERILE WATER FOR INJECTION,USP AND ONE TRANSFER DEVICE; FOR USE AS A
TOTAL PRIMARY CONTAINER QUANTITY: 1
~1: THROMBOLYTIC AGENT
Related Searches:
NDC12496-0757-01
BUPRENORPHINE HYDROCHLORIDE INJECTION
NSN, MFG P/N
6505013664754
NSN
6505-01-366-4754
NDC12496-0757-01
BUPRENORPHINE HYDROCHLORIDE INJECTION
NSN, MFG P/N
6505013664754
NSN
6505-01-366-4754
MFG
RECKITT AND COLMAN PHARMACEUTICAL INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.300 MILLIGRAMS BUPRENORPHINE EQUIVALENT
III CONTROLLED SUBSTANCE CLASSIFICATION: SCHEDULE V
III PART NAME ASSIGNED BY CONTROLLING AGENCY: BUPRENORPHINE HYDROCHLORIDE INJECTION 0.3MG AMPUL 10S
III PROTECTIVE STORAGE FEATURE: SECURITY STORAGE
PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS
PRIMARY CONTAINER TYPE: AMPUL
TOTAL PRIMARY CONTAINER QUANTITY: 10
Related Searches:
B9747
PERITONEAL DIALYSIS SOLUTION
NSN, MFG P/N
6505013665009
NSN
6505-01-366-5009
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.250 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 132.000 MILLIEQUIVALENTS SODIUM ION PER LITER AND 2.500 MILLIEQUIVALENTS CALCIUM ION PER LITER AND 95.000 MILLIEQUIVALENTS CHLORIDE ION PER LITER AND 0.5 MILLIEQUIVALENT MAGNESIUM ION PER LITER AND 40
PRIMARY CONTAINER CONTENT QUANTITY: 2000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 6
~1: MILLIEQUIVALENT LACTATE ION PER LITER
Related Searches:
5B9727
PERITONEAL DIALYSIS SOLUTION
NSN, MFG P/N
6505013665010
NSN
6505-01-366-5010
MFG
BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 2.500 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 132.000 MILLIEQUIVALENTS SODIUM ION PER LITER AND 2.500 MILLIEQUIVALENTS CALCIUM ION PER LITER AND 95.000 MILLIEQUIVALENTS CHLORIDE ION PER LITER AND 0.5 MILLIEQUIVALENT MAGNESIUM ION PER LITER AND 40
PRIMARY CONTAINER CONTENT QUANTITY: 2000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 6
~1: MILLIEQUIVALENT LACTATE ION PER LITER
Related Searches:
044-20204
PERITONEAL DIALYSIS SOLUTION
NSN, MFG P/N
6505013665011
NSN
6505-01-366-5011
044-20204
PERITONEAL DIALYSIS SOLUTION
NSN, MFG P/N
6505013665011
NSN
6505-01-366-5011
MFG
FRESENIUS USA INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 4.250 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 132.000 MILLIEQUIVALENTS SODIUM ION PER LITER AND 3.500 MILLIEQUIVALENTS CALCIUM ION PER LITER AND 96.000 MILLIEQUIVALENTS CHLORIDE ION PER LITER AND 0.5 MILLIEQUIVALENT MAGNESIUM ION PER LITER AND 40
PRIMARY CONTAINER CONTENT QUANTITY: 2000.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
TOTAL PRIMARY CONTAINER QUANTITY: 6
~1: MILLIEQUIVALENT LACTATE ION PER LITER